CrushSCI.com
Journal Selection & Manuscript Polishing Services
JOURNAL OF CLINICAL PHARMACOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

JOURNAL OF CLINICAL PHARMACOLOGY

Wiley SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q3
84.4Average days
71.5Median days
8Fastest days
215Longest days
1682025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

65 days

Population Pharmacokinetics and Exposure–Response of Sasanlimab, a Checkpoint Inhibitor, in Patients with Non‐Muscle Invasive Bladder Cancer and Other Solid Tumors

AuthorsJoanna C. Masters; Brian Jermain; Alan Liu; Rossano Cesari; Anna Maria Calella; Elisabete Michelon; Caimiao Wei; Susana Liu; Joseph Piscitelli

Affiliations1. Pfizer Inc. San Diego CA USA; 2. Pfizer Inc. New York NY USA; 3. Pfizer SRL Milan Italy; 4. Pfizer SRL Rome Italy; 5. Pfizer Inc. Quebec Canada

Source PDF DOI Publisher page
97 days

The Rise of the Digital Health Technology–AI Coupled System in the AI Era of Drug Development

AuthorsHanrui Zhang; Gabriel K. Innes; Jonas Santiago; Ayoub Suliman; Norah Xiao; Hao Zhu; Dianne Paraoan; Jeffery Siegel; Yutao Gong; Ruihao Huang; Menglun Wang; Lixia Zhang; Qi Liu

Affiliations1. Office of Clinical Pharmacology Office of Translational Sciences, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA; 2. Office of Medical Policy, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA; 3. Office of Drug Evaluation Sciences Office of New Drugs, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA

Source PDF DOI Publisher page
37 days

The Portability of Surrogate Endpoints

AuthorsHenry Bair

Affiliations1. Wills Eye Hospital Philadelphia PA USA

Source PDF DOI Publisher page
81 days

Volumetric Microsampling for Patient‐Centric Therapeutic Drug Monitoring in Clinical Pharmacology: A Scoping Review

AuthorsHari Prabhath Tummala; Abbie D. Leino; Nathaniel J. Rhodes; Kevin J. Downes; Marc H. Scheetz; Manjunath P. Pai

Affiliations1. Department of Clinical Pharmacy, College of Pharmacy University of Michigan Ann Arbor MI USA; 2. Division of Translational and Clinical Pharmacology Cincinnati Children's Hospital Medical Center Cincinnati OH USA; 3. Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH USA; 4. College of Pharmacy, Pharmacometrics Center of Excellence Midwestern University Downers Grove IL USA; 5. Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia PA USA; 6. Division of Infectious Diseases Children's Hospital of Philadelphia Philadelphia PA USA

Source PDF DOI Publisher page
98 days

Predicting Oral HIV Pre‐Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum

AuthorsYifan Yu; Kristina M. Brooks; Gustavo F. Doncel; Brookie M. Best; Mark A. Marzinke; Mark Mirochnick; Peter L. Anderson; Landon Myer; Connie Celum; Renee Heffron; Jenell Coleman; Dvora L. Joseph Davey; Lanxin Zhang; Max von Kleist; Craig W. Hendrix; Jeremiah D. Momper; Robert Bies; Rachel K. Scott

Affiliations1. School of Pharmacy and Pharmaceutical Sciences University at Buffalo Buffalo NY USA; 2. Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado‐Anschutz Medical Campus Aurora CO USA; 3. CONRAD Eastern Virginia Medical School Old Dominion University Norfolk VA USA; 4. Skaggs School of Pharmacy and Pharmaceutical Sciences University of California San Diego La Jolla CA USA; 5. Pediatrics Department University of California San Diego School of Medicine‐Rady Children's Hospital San Diego San Diego CA USA; 6. School of Medicine Johns Hopkins University Baltimore MD USA; 7. Chobanian & Avedisian School of Medicine Boston University Boston MA USA; 8. Division of Epidemiology and Biostatistics School of Public Health University of Cape Town Cape Town South Africa; 9. Departments of Global Health Medicine & Epidemiology miology University of Washington Seattle WA USA; 10. Department of Medicine University of Alabama at Birmingham Birmingham AL USA; 11. Division of Infectious Diseases Geffen School of Medicine University of California Los Angeles Los Angeles CA USA; 12. Project Group 5 “Systems Medicine of Infectious Disease” Robert‐Koch Institute Berlin Germany; 13. Medstar Health Washington DC USA; 14. Georgetown University School of Medicine Washington DC USA

Source PDF DOI Publisher page
8 days

Beyond Pharmacokinetics: Gaps for Rational Use of Medicinal Cannabis

AuthorsShuang Lu; Xin Liu; Linda Truong; Zheng Liu; Fei Guo; Jennifer Martin; Xiao Zhu

Affiliations1. Department of Clinical Pharmacy and Pharmacy Administration School of Pharmaceutical Sciences Fudan University Shanghai China; 2. Hunter Medical Research Institute Newcastle Australia; 3. School of Medicine and Public Health University of Newcastle Newcastle Australia; 4. Novella Clinical Full Service IQVIA Melbourne Australia; 5. Obstetrics & Gynecology Hospital of Fudan University Shanghai China; 6. National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers Fu dan University Shanghai China

Source PDF DOI Publisher page
22 days

THC Precision Dosing Requires Exposure Provenance and Psychiatric Phenotyping

AuthorsYu‐Yuan Hung; Lien‐Chung Wei

Affiliations1. Department of General Psychiatry, Taoyuan Psychiatric Center Ministry of Health and Welfare, Taoyuan City, Taiwan (Republic of China); 2. Department of Addiction Psychiatry, Taoyuan Psychiatric Cente Ministry of Health and Welfare, Taoyuan City, Taiwan (Republic of China); 3. Department of Health Industry Management Kainan University, Taoyuan City, Taiwan (Republic of China)

Source PDF DOI Publisher page
63 days

PBPK‐Based Prediction of Oliceridine Exposure in Breast Milk and Relative Infant Dose During the First 24 h After Cesarean Delivery

AuthorsYixi Ding; Ke Liu; Shuaishuai Zhang; Yanxu Zhang; Xin Tan; Weimin Xu

Affiliations1. School of Anesthesiology Shandong Second Medical University Weifang Shandong China; 2. Department of Anesthesiology Shengli Oilfield Central Hospital Dongying Shandong China

Source PDF DOI Publisher page
85 days

Simulation‐Based Evaluation of Busulfan Sampling Strategies in Adults and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

AuthorsZhiyuan Tan; Federica R. Achini‐Gutzwiller; Arjan C. Lankester; Joost G. K. van der Hem; Peter A. von dem Borne; Dirk Jan. A. R. Moes; Tim Preijers

Affiliations1. Department of Clinical Pharmacy & Toxicology Leiden University Medical Center Leiden The Netherlands; 2. Division of Systems Pharmacology and Pharmacy Leiden Academic Center for Drug Research Leiden University Leiden The Netherlands; 3. Department of Pediatrics Leiden University Medical Center Leiden The Netherlands; 4. Department of Hematology Leiden University Medical Center Leiden The Netherlands; 5. Department of Hospital Pharmacy Rotterdam Erasmus Medical Center Rotterdam The Netherlands

Source PDF DOI Publisher page
215 days

Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections

AuthorsSiddhee A. Sahasrabudhe; Satoshi Shoji; Abhijeet S. Jakate; Bisrat K. Abraham; Sima S. Toussi; Benjamin J. Maligalig; Amanda S. Darekar; Sakambari Tripathy; Constantino Kantaridis; Josue K. Mfopou; Oxana Selivanova; Arthur Bergman; Negar Niki Alami; Ravi Shankar P. Singh

Affiliations1. Pfizer Inc. Cambridge MA USA; 2. Pfizer R&D Japan Tokyo Japan; 3. Pfizer Inc. New York NY USA; 4. Pfizer Inc. Pearl River NY USA; 5. Pfizer Inc. Makati City Philippines; 6. Pfizer R&D UK Ltd. Tadworth Surrey UK; 7. Pfizer Inc. South San Francisco CA USA; 8. Pfizer CRU Brussels Belgium; 9. Pfizer Inc. Groton CT USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.